title: Spectrum of pulmonary neuroendocrine cell proliferation: diffuse idiopathic pulmonary neuroendocrine cell hyperplasia, tumorlet, and carcinoids.
abstract: OBJECTIVE
  The objectives of this article are to review the radiologic, pathologic, and clinical features of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia, tumorlet, and carcinoids and to discuss the possible role of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and tumorlet in the development of carcinoids.
  
  
  CONCLUSIONS
  Given the potential significant morbidity of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and its neoplastic counterparts, it is important to understand and recognize these disease entities. A conceptual continuum of these neuroendocrine entities is suggested.
authors: Department of Radiology, New York University Langone Medical Center, 560 First Ave., IRM 236, New York, NY 10016, USA. ChiWan.Koo@nyumc.org
authors: Chi Wan
authors: CW
authors: Koo
authors: Jeffrey P
authors: JP
authors: Baliff
authors: Drew A
authors: DA
authors: Torigian
authors: Leslie A
authors: LA
authors: Litzky
authors: Warren B
authors: WB
authors: Gefter
authors: Scott R
authors: SR
authors: Akers
mesh_terms: D002276:Carcinoid Tumor / Q000000981:diagnostic imaging / Q000473:pathology*; D049109:Cell Proliferation; D003287:Contrast Media; D003937:Diagnosis, Differential; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology*; D055099:Neuroendocrine Cells / Q000473:pathology*; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging / Q000473:pathology*; D009490:Neurosecretory Systems / Q000473:pathology; D011230:Precancerous Conditions / Q000000981:diagnostic imaging / Q000473:pathology; D012307:Risk Factors; D014057:Tomography, X-Ray Computed
chemical_list: D003287:Contrast Media